" And to update everyone on Regentys all the necessary manufacturing testing and trial plans for our liquid hydrogel products for Crohn's disease _____ [00:11:42] ready to start trials. And we are awaiting the necessary funding from our S-1 to start these trials. We are very eager to start this work and we are confident this would add huge value to the future of Generex."
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links